Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion. [electronic resource]
- Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 10 2017
- 1378-1386 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1530-0285
10.1038/modpathol.2017.63 doi
Abnormal Karyotype Adult Aged Aged, 80 and over Female Gene Deletion Humans Kaplan-Meier Estimate Male Middle Aged Multiple Myeloma--genetics Prognosis Retrospective Studies Tumor Suppressor Protein p53--genetics